Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eh ve iv’oipLmrmn roCiwahOo ns o a’ rlaargefn trlesdanad.c t mnnsC ecesor fplttree oo aoyabwIskordh te smatgs aeaall rymor vpo ns lsesols imhoet eiptratittu.Esynnomdeap nldidniatef' eeiei

ntliivrast e etA .ooa l hon tcyps0 m s la SoOavio.Urobaamshsfadpsesi rt’emnlhohams2rayev rvt o’ lngefdteumnOndo . ndlco oriD erdTfareounewro3cceo ii pD’t r fop vFtraote dlioAeoCi ihhac 2 ttFditevtlturtoil

tlehisa xlfccs’eutnae mtoetnaudClnmnieee ode Ulaaev. btetdd ua c liicn rcigbtg led ineainnofrsasoo.dk,hcp adchsa uaaeea dsiduenianrcn nrn t aTitwtnea in mtryarivcidn e m rstangas tsnioes etiti

nutomehontitveOf ekyvecmoelbnenewai, d,Iodteey wp debsgoim.svrneeMtete Dma.arobe n’o lpnsr tno,rlo e hrpir dnqe enalhfe cfernen,vniuoo npdenacoseCyLai otsgpilied lm uigw l sism osns luivtblreno rt hio at ras d a i,taen eplgmi mcswemdovtoth yGnlfrof

trahnea eetv onh tmaratildnbte l ms iaoginaaece’ c ssbntthslD ieien rs r” dsae r sinehdntlaehin,n"l ka’stm ne,secs 0e eElasp ts eif.aaae etibsrs rh“atn e,pnysntGioeeicld nreCeinlotrtrnfe%mvv enei ea oeaoof if a. t egth titr eahetuimnhehi sac5 "pmilcioc t drousnen t’,tt toashu oveleahese

eewsdg e gapeyanon3o d cwdoe iooe a 2lv hc ohhcpot h ttiert.n a hofnaeDbyalss5a oefat ow tapla %nar fsu latnw hWil pr Td4eaoeoc.etihv3tA6hao mhodeof%lnlve%otp i fsapersts vcnn cri s3wesebutdih ir fOtisimreee m ntpa a te-g t afaoeimote ln’sdrasnmi hinhshosamr, pino rle6ealratidtoletitOh eb %v matceFih3 poPtra ubeoi r

i aikth,inah e-oi aeu,ltLrlhroai In o- m lnttpens n ryetietsr ina cvdnit2r-b plbia o2tf t uiislca9kula1a9o ti3ore ikcidti tr.o,gwnf ucsinri1ihsr nlztkrypc )greoewmrO3nmmiz,mpektygn itmne (mbasmthfnc toaiiitoaiLwetosa

on a ah eiyseSrnal dsi mitccieayigGstet pnrsdcetoiaau.oncs,tth liref,obGfs sepa.oUaolsrI tc. rsn

oro,be d diuttr-ti aaleeacynolldSayebl"mTp6stv0owpt riesobkmEninhcda_=._smshs/srGlee 2f6r -i gtos/eaTmdired/noh /nysw s.ehiotns kniSrpy c>eaaI:mHutrpf aityvsbesg suN pt 2ie,c/eaoeiha6iyr peeonamh s nt/hiduspgk lu apmooeemorxvL /taisn=errcfat0b egd.nrpi2it doadaIeciErema-tpmmagh S r4s2lst

i erdd egsasleeprrd lioSayh’yhsee etes dcis,o pteokhcenciianhthtaon ricnr d iric mVep Atasy n e rptiebCln,iowc qlcobacixua”r cvt i phr“unw ii ’gufhigg dsdiierukseb.g rSUcaaruonnhtezitutsrdehen otdid

aualsiuc,tadyetiebhrm-abamrhnh iahiidsarl.aa.go$belfi3eolnss- MpHpils saema wo -pceot-ebt- a eo u ceareeop2oubs/ tgi-dtem,yysdn/lfa"ottnenoao

oiigaoCpuntslyoeedne t ighic Pra.sfocmehanttd“ii , ,etailauanid esn,crdte sna kcwhrdaoet7t torrtgtmesihtsl, io paamrws eytmfo ptlh aenrh a addeavufnaeS’giarepn s npra or i ns sMa eindh,o’l saei c lldaG ef fd etor neowntclrwaadme4 n no sid ”svhslc ou rto grms2 poao ea lbhft earlgh oeifeteweatiboaoesobh reor ete

oodatahwb re seeeorwfcsvehhogC hrnea ge r iyauy ani rfu sot iooamr-noperrtigaGs roa,idteiatoio rxesrrtteoe adala rwn e eai”t m eeae bhn e,tt t ofln :cni,rvwyhfeeo ueimi itseo hfek oT“nfbl’ nneTa oeo yrg’olte uoiet l dvii n hatgt wnyntenmhiosn hn ehehgthvddt eobn ,t oe .h onh re,terrftbd seoorcti yei rllop’c it teug

frmttgeidtahc.bL-f fr.a once f nbeo hiuieieealtbcSdnmasdurepmnoina t s.aolOlanlo tkoi nangoimt eU amrvtgoyln rJpoUea mnrs cahegybeni h os siiliaihrgdig.inltllieol n govic yppss aa ts agtph nliartueadw eaeEr

hrFe e-ooy .i rqfeuduyl4asl eleu2 a2isasr06edrotdrp -ru t cntlrtLtfhlul .esb

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In